Trends is free while in Beta
9999%+
(5y)
9999%+
(1y)
9999%+
(3mo)

About Toragesic

Toragesic is a brand of cetorolac trometamol (an NSAID) used for short term management of moderate to severe acute pain, available in sublingual tablets, oral solutions, and injectables, with widespread availability in Brazil and other markets.

Trend Decomposition

Trend Decomposition

Trigger: Increased consumer and clinician attention to fast acting analgesics for acute pain, driving demand for sublingual and oral NSAIDs like Toragesic.

Behavior change: Patients and providers prefer rapid onset, non opioid analgesia options for post surgical or acute pain scenarios.

Enabler: Availability of sublingual formulations and ready to use NSAID solutions; digital catalogs and pharmacy networks enabling quick procurement.

Constraint removed: Reduced reliance on injectable or opioid analgesics for certain acute pain indications through easy to administer NSAID forms.

PESTLE Analysis

PESTLE Analysis

Political: Regulatory approvals and naming standards for NSAIDs influence market access across regions.

Economic: OTC and prescription NSAID sales contribute to healthcare cost management by offering affordable analgesia options.

Social: Growing emphasis on non opioid pain management and patient preference for rapid, at home relief.

Technological: Advances in pharmaceutical formulation enable sublingual and liquid NSAID delivery with rapid onset.

Legal: Drug safety labeling and contraindications for NSAIDs shape prescribing and patient access.

Environmental: Packaging and distribution logistics for multiple dosage forms impact environmental footprint of analgesic medicines.

Jobs to be done framework

Jobs to be done framework

What problem does this trend help solve?

Provides rapid, non opioid pain relief for acute conditions.

What workaround existed before?

Reliance on opioids or slower acting analgesics; injections or systemic NSAIDs with longer onset.

What outcome matters most?

Speed of onset and reliability of pain relief with minimal central nervous system effects.

Consumer Trend canvas

Consumer Trend canvas

Basic Need: Effective acute pain management with rapid relief.

Drivers of Change: Demand for non opioid options; faster administration routes; growing pharmacy distribution networks.

Emerging Consumer Needs: Easy to take forms (sublingual, oral solutions); safety profiles suitable for short term use.

New Consumer Expectations: Quick onset, minimal sedation, clear dosing and safety information.

Inspirations / Signals: Rising online pharma catalogs; multiple regional approvals for sublingual NSAIDs.

Innovations Emerging: Sublingual tablet technology; improved taste masked and fast dissolving formulations.

Companies to watch

Associated Companies